CD8A and neoplasm: Failure of this mechanism occurs due to the tumor’s ability to inhibit the immune activation of antigen-presenting cells, CD8+TIL and Natural Killer (NK), and involve some trans-membrane proteins such as Programmed Cell Death protein 1 (PD-1) and its ligand PD-L1.